SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 27.52-2.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: H.J. Schellenberg who wrote (377)1/30/1997 4:39:00 PM
From: Mike Relyea   of 1693
 
H.J.,

Have you ever played the basketball game "HORSE," where you've got to make the second shot before the first one counts? Maybe the market's playing a similar game with Quidel.

I'm also surprised Quidel's stock is not selling for more, considering its 3rd quarter earning were quite a bit higher than Van Kasper and Principal Securities forecast. I also wouldn't be surprised to see Quidel shoot up to $10 or more very quickly on a positive announcement, good press, or a strong buy recommendation.

I expect Quidel will have a stellar fourth Quarter for reasons that have been pointed out on this thread. The market will "discover" Quidel any day, and its stock price will then more fairly reflect its earnings potential. In the mean time, consider its current price a buying opportunity.

I don't know why Quidel didn't mention the Trinity or Saliva in its last report. However, Quidel's near term success will depend on Quidel increasing its earnings, not on what happens with Trinity or Saliva.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext